Misplaced Pages

Talk:Beta blocker: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 03:37, 18 October 2017 editBiochemistry&Love (talk | contribs)Extended confirmed users, New page reviewers5,950 edits →Unsourced: Cite.← Previous edit Revision as of 03:44, 18 October 2017 edit undoBiochemistry&Love (talk | contribs)Extended confirmed users, New page reviewers5,950 edits →Unsourced: Cited.Next edit →
Line 70: Line 70:
*Agents specifically labeled for glaucoma *Agents specifically labeled for glaucoma
**],<ref name="Aronson" /> ],<ref name="Aronson" /> ],<ref name="Aronson" /> ],<ref name="Aronson" /> ]<ref>{{cite web|title=DailyMed - METIPRANOLOL- metipranolol solution/ drops|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3|website=dailymed.nlm.nih.gov|publisher=NIH|accessdate=18 October 2017}}</ref> **],<ref name="Aronson" /> ],<ref name="Aronson" /> ],<ref name="Aronson" /> ],<ref name="Aronson" /> ]<ref>{{cite web|title=DailyMed - METIPRANOLOL- metipranolol solution/ drops|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3|website=dailymed.nlm.nih.gov|publisher=NIH|accessdate=18 October 2017}}</ref>
*Agents specifically labeled for myocardial infarction *Agents specifically labeled for myocardial infarction<ref name="PharmLetter BB Table" />
**], ], ] **], ] (immediate release), ] (immediate release), ], ] (after left ventricular dysfunction)
*Agents specifically labeled for migraine prophylaxis<ref name="PL Chart Migraine">{{cite web|title=Drugs to Prevent Migraine in Adults|url=https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2012/Jul/Drugs-to-Prevent-Migraine-in-Adults-4513|website=pharmacist.therapeuticresearch.com|publisher=Therapeutic Research Center|accessdate=30 April 2017}}</ref> *Agents specifically labeled for migraine prophylaxis<ref name="PL Chart Migraine">{{cite web|title=Drugs to Prevent Migraine in Adults|url=https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2012/Jul/Drugs-to-Prevent-Migraine-in-Adults-4513|website=pharmacist.therapeuticresearch.com|publisher=Therapeutic Research Center|accessdate=30 April 2017}}</ref>
**], ] **], ]

Revision as of 03:44, 18 October 2017

Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Beta blocker.
This is the talk page for discussing improvements to the Beta blocker article.
This is not a forum for general discussion of the article's subject.
Article policies
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Archives: 1Auto-archiving period: 2 months 
WikiProject iconPharmacology C‑class Top‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
CThis article has been rated as C-class on Misplaced Pages's content assessment scale.
TopThis article has been rated as Top-importance on the project's importance scale.


Unsourced

Moved here per WP:PRESERVE as this is almost all unsourced. Per WP:BURDEN please do not restore without finding reliable sources, checking the content against them, and citing the sources.

Examples
Dichloroisoprenaline, the first beta blocker
Nonselective agents
β1-selective agents

Also known as cardioselective

β2-selective agents
β3-selective agents
Comparative information
Pharmacological differences
  • Agents with intrinsic sympathomimetic action (ISA)
    • Acebutolol, pindolol, labetalol, mepindolol, oxprenolol, celiprolol, penbutolol
  • Agents organized by lipid solubility (lipophilicity)
    • High lipophilicity: propranolol, labetalol
    • Intermediate lipophilicity: metoprolol, bisoprolol, carvedilol, acebutolol, timolol, pindolol
    • Low lipophilicity (also known as hydrophilic beta-blockers): atenolol, nadolol, and sotalol
  • Agents with membrane stabilizing effect
    • carvedilol, propranolol > oxprenolol > labetalol, metoprolol, timolol
Indication differences

Propranolol is the only agent indicated for control of tremor, portal hypertension, and esophageal variceal bleeding, and used in conjunction with α-blocker therapy in phaeochromocytoma.

References

  1. ^ "Comparison of Oral Beta-Blockers". pharmacist.therapeuticresearch.com. Therapeutic Research Center. Retrieved 30 April 2017.
  2. Rosendorff C (1993). "Beta-blocking agents with vasodilator activity". Journal of Hypertension. Supplement. 11 (4): S37–40. doi:10.1097/00004872-199306003-00009. PMID 8104240.
  3. "CARTEOLOL". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 18 October 2017.
  4. ^ "oxprenolol". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 18 October 2017.
  5. ^ "Celiprolol". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 18 October 2017.
  6. "Butaxamine". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 18 October 2017.
  7. "ICI 118551 hydrochloride". abcam.com. Abcam plc. Retrieved 18 October 2017.
  8. "SR 59230A". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine. Retrieved 18 October 2017.
  9. ^ Larochelle, Pierre; Tobe, Sheldon W.; Lacourcière, Yves (May 2014). "β-Blockers in Hypertension: Studies and Meta-analyses Over the Years". Canadian Journal of Cardiology. 30 (5): S16 – S22. doi:10.1016/j.cjca.2014.02.012. {{cite journal}}: |access-date= requires |url= (help); no-break space character in |title= at position 59 (help)
  10. Mulrow, edited by Detlev Ganten, Patrick J. (1990). Pharmacology of Antihypertensive Therapeutics. Berlin, Heidelberg: Springer Berlin Heidelberg. p. 523. ISBN 9783642742095. {{cite book}}: |access-date= requires |url= (help); |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  11. Zipursky, Jonathan S.; Macdonald, Erin M.; Luo, Jin; Gomes, Tara; Mamdani, Muhammad M.; Paterson, J. Michael; Juurlink, David N. (June 2017). "Lipophilic β-Blockers and Suicide in the Elderly". Journal of Clinical Psychopharmacology. 37 (3): 381–384. doi:10.1097/JCP.0000000000000695. Retrieved 18 October 2017.
  12. ^ Aronson, Jeffrey K (1 June 2008). "Changing beta-blockers in heart failure: when is a class not a class?". British Journal of General Practice. 58 (551): 387–389. doi:10.3399/bjgp08X299317. {{cite journal}}: |access-date= requires |url= (help)
  13. "DailyMed - METIPRANOLOL- metipranolol solution/ drops". dailymed.nlm.nih.gov. NIH. Retrieved 18 October 2017.
  14. "Drugs to Prevent Migraine in Adults". pharmacist.therapeuticresearch.com. Therapeutic Research Center. Retrieved 30 April 2017.
  15. Cite error: The named reference Rossi was invoked but never defined (see the help page).
Categories: